AU2002324881A8 - Diagnostic and prognostic tests - Google Patents

Diagnostic and prognostic tests

Info

Publication number
AU2002324881A8
AU2002324881A8 AU2002324881A AU2002324881A AU2002324881A8 AU 2002324881 A8 AU2002324881 A8 AU 2002324881A8 AU 2002324881 A AU2002324881 A AU 2002324881A AU 2002324881 A AU2002324881 A AU 2002324881A AU 2002324881 A8 AU2002324881 A8 AU 2002324881A8
Authority
AU
Australia
Prior art keywords
diagnostic
prognostic tests
prognostic
tests
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002324881A
Other versions
AU2002324881A1 (en
Inventor
Raphael Bueno
Roderick V Jensen
Gavin J Gordon
Steven R Gullans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wesleyan University
Original Assignee
Wesleyan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wesleyan University filed Critical Wesleyan University
Priority claimed from US10/236,031 external-priority patent/US7622260B2/en
Publication of AU2002324881A1 publication Critical patent/AU2002324881A1/en
Publication of AU2002324881A8 publication Critical patent/AU2002324881A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002324881A 2001-09-05 2002-09-05 Diagnostic and prognostic tests Abandoned AU2002324881A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31738901P 2001-09-05 2001-09-05
US60/317,389 2001-09-05
US10/236,031 2002-08-30
PCT/US2002/028203 WO2003021229A2 (en) 2001-09-05 2002-09-05 Diagnostic and prognostic tests
US10/236,031 US7622260B2 (en) 2001-09-05 2002-09-05 Diagnostic and prognostic tests

Publications (2)

Publication Number Publication Date
AU2002324881A1 AU2002324881A1 (en) 2003-03-18
AU2002324881A8 true AU2002324881A8 (en) 2003-03-18

Family

ID=26929397

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002324881A Abandoned AU2002324881A1 (en) 2001-09-05 2002-09-05 Diagnostic and prognostic tests

Country Status (2)

Country Link
AU (1) AU2002324881A1 (en)
WO (1) WO2003021229A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635676B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7622260B2 (en) 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
JP2007526749A (en) * 2003-07-02 2007-09-20 ノバルティス アクチエンゲゼルシャフト Genes regulated in ovarian cancer as a prognostic and therapeutic target
WO2005015236A2 (en) * 2003-07-18 2005-02-17 Roche Diagnostics Gmbh A method for predicting the progression of adenocarcinoma
EP2157524A3 (en) 2003-09-03 2010-12-08 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Methods for identifying, diagnosing, and predicting survival of lymphomas
US20110152115A1 (en) 2003-09-03 2011-06-23 The United States of America, as represented by the Secretary, Department of Health and Methods for identifying, diagnosing, and predicting survival of lymphomas
US8131475B2 (en) 2003-09-03 2012-03-06 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for identifying, diagnosing, and predicting survival of lymphomas
US20050071087A1 (en) 2003-09-29 2005-03-31 Anderson Glenda G. Systems and methods for detecting biological features
US8321137B2 (en) 2003-09-29 2012-11-27 Pathwork Diagnostics, Inc. Knowledge-based storage of diagnostic models
EP1533619B1 (en) * 2003-11-20 2009-04-29 F. Hoffmann-Roche AG Specific markers for metabolic syndrome
WO2008021115A2 (en) 2006-08-14 2008-02-21 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
JP5415963B2 (en) * 2007-02-21 2014-02-12 オスロ ユニベルシテートシケヒュース ホーエフ New cancer marker
US20110195064A1 (en) 2008-06-06 2011-08-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Survival predictor for diffuse large b cell lymphoma
AU2015251314A1 (en) * 2014-04-22 2016-11-03 Shanghai Kexin Biotech Co., Ltd. Method and biomarker for detecting cancer
CN104368012B (en) * 2014-08-20 2019-03-22 中国人民解放军第三〇七医院 The purposes and its related drugs of people's RPL34 gene
CN107312846A (en) * 2017-07-12 2017-11-03 北京赛尔维康生物医学科技有限公司 Application of the CAPG and PTGIS genes in scoliosis detection kit is prepared
CN111912987B (en) * 2020-08-25 2023-07-21 北京信诺卫康科技有限公司 FGF18 and HE4 combined used as early ovarian cancer biomarker and kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5840484A (en) * 1992-07-17 1998-11-24 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
WO2000055633A2 (en) * 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Methods of screening for colorectal cancer modulators

Also Published As

Publication number Publication date
AU2002324881A1 (en) 2003-03-18
WO2003021229A2 (en) 2003-03-13
WO2003021229A3 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
AU2002327185A8 (en) Diagnostic methods and devices
GB0104690D0 (en) Diagnostic test
IL160342A0 (en) Test enabled application execution
GB0127322D0 (en) Test device
AU149115S (en) Analyte test strip
EP1413880A4 (en) Analyzing instrument
AUPQ886100A0 (en) Diagnostic test
AU2002324881A8 (en) Diagnostic and prognostic tests
AU2002367856A8 (en) Diagnostic device
GB0128310D0 (en) Test
GB0224326D0 (en) Diagnostic tests
GB0120009D0 (en) Cause and effect diagnosis
EP1412754A4 (en) Diagnostic methods and agents
GB0229444D0 (en) Diagnostic method and assay kit
GB0125180D0 (en) Diagnostic tests
TW549448U (en) Probe card assembly
GB0121996D0 (en) Diagnostic test
GB0025678D0 (en) Diagnostic test
AU2002252875A1 (en) Cardiovascular disease and thrombotic risk diagnostic tests
GB0116311D0 (en) Non-destructive testing
GB0219890D0 (en) Diagnostic test
EP1405069A4 (en) See through testing device
GB0115270D0 (en) Blood testing unit
AU2002251518A1 (en) Immunochromatographic test piece and diagnosis kit
GB9824213D0 (en) Diagnostic test

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase